Senior Scientist, Pharmacoepidemiology & Safety

Genesis Research Group
united kingdom, united kingdom
2 months ago
Create job alert

Genesis is one of the leading evidence generation consultancies providing agile, tech-enabled real-world evidence (RWE), as well as health economics and outcomes research (HEOR) solutions to clients in the pharmaceutical, biotech, and medical device industries. Since 2009, we’ve partnered with our clients to develop impactful evidence across the product lifecycle to optimize market access for novel healthcare innovations and satisfy regulatory, provider, and payer evidence requirements. Genesis is database agnostic, regularly working across many structured and unstructured real-world data sources. As a company, we deliver services across many RWE and HEOR applications and a wide range of therapeutic areas with an emphasis on uncompromising quality, scientific rigor, and flexible solutions.



The Pharmacoepidemiology and Safety team and this position:


The Genesis pharmacoepidemiology and safety team consists of scientific experts who lead study design, methodology development, and result interpretation across a broad range of regulatory and safety RWE studies. The individual in this role will demonstrate a passion for the generation of rigorous and relevant RWE, ensuring delivery of high-quality evidence in a timely manner to fully meet our clients’ needs. This position will report to a Director or Senior Director in Pharmacoepidemiology and Safety.


Accountabilities within this role:


  • Develop scientifically-sound, clear, concise RWE deliverables related to study design, methodology, and result interpretation (for example: study concept sheets, protocols, analysis results/interpretation, final study reports, slide decks, regulatory briefing books, risk management plans, manuscripts etc.).
  • Contribute effectively to a team of pharmacoepidemiologists, biostatisticians, and analysts charged with designing, implementing, and managing a wide range of studies to assess the utilization, effectiveness, and safety of medicinal products.
  • Collaborate within the organization as it relates to pharmacoepidemiology and safety by supporting cross-functional teams through the design, execution, and delivery of high-priority and high-visibility RWE studies.
  • Ensure best practices with respect to RWD data source selection and research methodology, assessing strengths and limitations when designing studies; appropriately accounting for implications of underlying RWD generation mechanisms and medical coding practices.
  • Cultivate a positive work environment.


Qualifications:


  • Master’s degree or PhD within a relevant discipline (e.g., Pharmacoepidemiology or Epidemiology focus on methods and study execution)
  • 4+ years for Master’s degree or 2+ years for PhD of consulting, industry, or academic experience
  • Experience generating and interpreting real-world and observational research
  • Experience designing and executing studies using claims and/or EHR databases
  • Strong regulatory and life sciences industry knowledge
  • Excellent verbal and written communication skills
  • Proficiency in relevant software such as MS office (Word, Excel and PowerPoint)
  • Exceptional organizational skills and attention to detail
  • Enthusiasm to learn and motivation to develop oneself and others within Genesis Research
  • Flexibility to adapt to client project needs and handle competing priorities in a fast-paced workplace


Compensation:


  • Competitive salary
  • Performance-related bonus
  • Flexible Paid Time Off
  • Employer matched pension plan
  • Private Medical Insurance

Related Jobs

View all jobs

Senior Clinical Information Scientist

Senior Scientist - Biocompatibility

Senior Scientist - Organic Chemist, High-Throughput Experimentation

Senior Modelling & Simulation Scientist

Senior Environmental Scientist

Senior Clinical Scientist (Senior Director) – Oncology - Global Role

Get the latest insights and jobs direct. Sign up for our newsletter.

By subscribing you agree to our privacy policy and terms of service.

Industry Insights

Discover insightful articles, industry insights, expert tips, and curated resources.

Contract vs Permanent Biotech Jobs: Which Pays Better in 2025?

In the ever-advancing world of life sciences, biotechnology has emerged as one of the fastest-growing and most impactful sectors in the UK. From gene editing and regenerative medicine to synthetic biology and vaccine development, British biotech organisations are at the forefront of scientific innovation. With this growth comes a high demand for skilled professionals—scientists, data analysts, regulatory affairs specialists, bioprocess engineers, and more—who can help bring cutting-edge treatments and products to market. However, as the biotechnology landscape in the UK continues to expand, so too do the ways in which professionals choose to work. Beyond traditional permanent employment, many biotech specialists are exploring the world of contracting, which can take the form of day‑rate consulting or fixed-term contracts (FTC). Each path promises unique advantages and disadvantages, from pay rates and benefits packages to career development and job security. This article offers a comprehensive guide on contract vs. permanent biotech jobs in 2025. We will explore how the UK biotech sector is shaping up, break down the different types of employment arrangements, and present sample take‑home pay scenarios for each. Our goal is to empower you with the knowledge needed to make an informed decision that aligns with both your financial aspirations and long-term career goals within the vibrant and evolving biotech industry.

Biotech Jobs for Non‑Technical Professionals: Where Do You Fit In?

Your Place in Britain’s Biotech Boom When most people picture biotechnology careers they imagine pipettes, petri dishes and white‑coated scientists in Cambridge or Oxford. Yet for every bench scientist there is an ecosystem of professionals who never set foot in the lab but are crucial to getting a therapy, diagnostic or food‑tech breakthrough to market. The UK BioIndustry Association (BIA) reports that non‑scientific vacancies now make up more than one‑third of all biotech job ads, and demand is accelerating. According to Vacancysoft’s Life Sciences Labour Market Trends (November 2024), biotech job postings in the Golden Triangle jumped 26 % year‑on‑year, with hotspots also emerging in Birmingham and Glasgow. Finance is following suit: the sector attracted £3.5 billion in investment during 2024, a 94 % rebound from 2023 levels. More capital means more hires in project management, regulatory affairs, and commercial operations. In short, biotech is not just for PhDs, and you don’t need to master CRISPR to make an impact. This guide explains the high‑growth, non‑technical roles; the transferable skills you already possess; real‑life transition stories; and a step‑by‑step plan to pivot into the UK’s most exciting industry.

Johnson & Johnson Biotech Jobs in 2025: Your Complete UK Guide to Joining the World’s Largest Healthcare Innovator

From the first mass‑produced sterile surgical dressings in the 1880s to first‑in‑class CAR‑T cell therapies in the 2020s, Johnson & Johnson (J&J) has continuously re‑invented healthcare. Following the 2024 spin‑off of its consumer division (Kenvue) and the rebrand of Janssen to Johnson & Johnson Innovative Medicine, the company now focuses squarely on pharmaceutical innovation, med‑tech and vision care. With revenues exceeding US $90 bn and a pipeline spanning oncology, immunology, vaccines and digital surgery, J&J remains a magnet for biotech talent. A quick scan of the Johnson & Johnson careers portal shows over 2,000 open roles in EMEA, with nearly 300 in the UK, across R&D, manufacturing, clinical affairs and data science. This guide explains how to land a Johnson & Johnson biotech job in 2025—from graduate scientist to principal data engineer.